Herpetic Eye Disease Is Not a Single Event - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Herpetic Eye Disease Is Not a Single Event

Joseph P. Shovlin, OD, FAAO, reviewed diagnosis, management, and emerging evidence related to chronic herpetic eye disease prevention at Optometry's Meeting 2026.

  • By

  • Deborah Fisher

  • June 17, 2026

  • 3 min

Share

Objective:

To provide a comprehensive clinical review of ocular herpes simplex virus (HSV) and herpes zoster virus (VZV), focusing on diagnosis, management, and chronic disease prevention.

Approach:
    Key Findings:
    • HSV-1 is the most common ocular viral pathogen.
    • HZO prevalence is increasing with an aging population.
    • Both HSV and VZV can reactivate due to declining immunity.
    • Differentiating between infectious and immune-mediated diseases is critical for treatment.
    • Emerging evidence supports long-term suppressive therapy for HZO.
    Interpretation:

    The presentation emphasizes the importance of recognizing herpetic eye disease patterns to prevent misdiagnosis and complications.

    Limitations:
    • The study does not address the effectiveness of treatments in all patient populations.
    • Long-term outcomes of new treatment strategies are not fully established.
    Conclusion:

    Early recognition and management of herpetic eye disease are crucial for preserving vision and reducing complications.

    Sources:

Original Source(s)

Herpetic Eye Disease Is Not a Single Event

  • by Deborah Fisher

  • June 17, 2026

Related Content

New Appointment for The Retina Clinic London

Clinic expands cataract and medical retina expertise with appointment of consultant ophthalmic surgeon

  • July 13, 2026

  • 2 min
Immune-Mediated Inflammatory Diseases Following Pediatric Uveitis Diagnosis

Imaging Leukocyte Dynamics in Retinal Disease

The movement of immune cells through the retinal vasculature has long been inferred from laboratory models. Now, advances in imaging are allowing clinicians to observe these processes directly. At the 2026 meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Denver, Richard B. Rosen, MD, ScD(hon), FACS, FASRS, FARVO, described early clinical work using adaptive optics scanning laser ophthalmoscopy (AOSLO) to visualize leukocyte trafficking in vivo.